Drug intelligence / Profile preview

washed leukoreduced irradiated blood cell transfusions

Development stage
Unknown
Lead developer
University of Rochester
Modality
Cell Therapies
Administration
Intravenous
01

Overview

Washed leukoreduced irradiated blood cell transfusions represent a specialized blood product preparation used to minimize transfusion-related complications in high-risk patients, such as children undergoing congenital heart surgery. The preparation involves three distinct processing steps: **washing** with saline to remove plasma proteins, potassium, and inflammatory cytokines (such as IL-6); **leukoreduction** (typically via filtration) to remove donor white blood cells, thereby reducing the risk of febrile non-hemolytic reactions and HLA alloimmunization; and **irradiation** (using gamma or X-rays) to inactivate donor T-lymphocytes and prevent transfusion-associated graft-versus-host disease (TA-GVHD). This specific combination of processing is being investigated by the University of Rochester to determine its impact on post-operative inflammation and clinical outcomes in pediatric cardiac surgery.

Other names
washed leukoreduced irradiated red blood cellswashed leukoreduced irradiated blood cells

Beyond the preview

Go deeper on washed leukoreduced irradiated blood cell transfusions.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on washed leukoreduced irradiated blood cell transfusions.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call